Migraine cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 16: Line 16:
[[Category:Primary care]]
[[Category:Primary care]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Signs and symptoms]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Headaches]]
[[Category:Headaches]]
[[Category:Head and neck]]
[[Category:Head and neck]]

Revision as of 12:21, 10 June 2015

Migraine Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Triggers

Differentiating Migraine from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Treatment

Medical Therapy

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Migraine cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Migraine cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Migraine cost-effectiveness of therapy

CDC on Migraine cost-effectiveness of therapy

Migraine cost-effectiveness of therapy in the news

Blogs on Migraine cost-effectiveness of therapy

Directions to Hospitals Treating Migraine

Risk calculators and risk factors for Migraine cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatments are typically expensive. Periodic or unpredictable disability can cause impoverishment due to patients' inability to work enough or to hold a job at all.

Cost-Effectiveness of Therapy

In addition to being a major cause of pain and suffering, chronic migraine attacks are a significant source of both medical costs and lost productivity. Medical costs per migraine sufferer (mostly physician and emergency room visits) averaged $107 USD over six months in one 1988 study, with total costs including lost productivity averaging $313. Annual employer cost of lost productivity due to migraines was estimated at $3,309 per sufferer. Total medical costs associated with migraines in the United States amounted to one billion dollars in 1994, in addition to lost productivity estimated at thirteen to seventeen billion dollars per year. Employers may benefit from educating themselves on the effects of migraines in order to facilitate a better understanding in the workplace. The workplace model of 9-5, 5 days a week may not be viable for a migraine sufferer. With education and understanding an employer could compromise with an employee to create a workable solution for both.

References

Template:WH Template:WS